Form 4: Surrozen Director Acquires Stock Options

Christopher Y. Chai, a director at Surrozen, Inc., acquired 5,550 stock options.

Summary

• Christopher Y. Chai, a director of Surrozen, Inc., was granted 5,550 stock options.
• The options have an exercise price of $30.14 and are exercisable starting May 13, 2027.
• The expiration date for these options is May 12, 2036.
• These options vest and become exercisable on the anniversary of the grant date, contingent on continued service as a director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation grant to a director rather than a significant financial event or strategic shift.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The grant of options to a director aligns their interests with those of shareholders.

Risks

• The value of the stock options is dependent on the future performance of Surrozen, Inc.'s stock price.
• Vesting is contingent on continued service, meaning the options could be forfeited if the director leaves the company.

Future Outlook

The future outlook for the stock options is tied to the company's performance and stock price appreciation, as the options are exercisable at $30.14 and expire in 2036.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize long-term commitment and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The alignment of director interests with shareholders is generally positive, but the dilutive effect of future option exercises should be considered.
• Employees: This filing does not directly impact employees, but it reflects standard compensation practices within the company.
• Management: The filing confirms a standard compensation package for a director.

Next Steps

• Christopher Y. Chai will continue to serve as a director, subject to vesting conditions.
• The stock options will become exercisable on May 13, 2027, and will expire on May 12, 2036.

Key Dates

Keywords

Surrozen Inc, SRZN, Form 4, Stock Options, Director Compensation, Beneficial Ownership, SEC Filing